retatrutide weight loss trial retatrutide Retatrutide: FDA approval time, results & Retatrutide: What It Is &

Potential Effects on Perimenopausal Symptoms Reduced Hot Flushes Weight loss has been linked to a reduction in the frequency and intensity of hot flushes, one of the most common and distressing symptoms experienced during perimenopause

Are there different types of GLP-1 medications

More recently the potent GLP-1 RA, semaglutide, and the dual GLP-1/GIP receptor agonist, Tirzepatide has also been approved for weight loss indications

Telehealth peptide prescriptions expose longevity industry stretching the rules Mon 20 Jul 2026 at 4:44am , updated Mon 20 Jul 2026 at 6:10am The booming industry selling Australians on the promise of living longer and turning back the clock on aging is exploiting significant gaps in health regulation, exposing consumers to risk